In vivo assessment of microvascular nitric oxide production and its relation with blood flow
Unidad de Regulación Neurohumoral, Departamento de Ciencias Fisiológicas, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile 6513492 To assess the hypothesis that microvascular nitric oxide (NO) is critical to maintain blood flow and solute exchange, we quanti...
Gespeichert in:
Veröffentlicht in: | American journal of physiology. Heart and circulatory physiology 2001-03, Vol.280 (3), p.H1222-H1231 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Unidad de Regulación Neurohumoral, Departamento de Ciencias
Fisiológicas, Facultad de Ciencias Biológicas, Pontificia
Universidad Católica de Chile, Santiago, Chile 6513492
To assess the hypothesis that
microvascular nitric oxide (NO) is critical to maintain blood flow and
solute exchange, we quantified NO production in the hamster cheek pouch
in vivo, correlating it with vascular dynamics. Hamsters (100-120
g) were anesthetized and prepared for measurement of microvessel
diameters by intravital microscopy, of plasma flow by isotopic sodium
clearance, and of NO production by chemiluminescence. Analysis of
endothelial NO synthase (eNOS) location by immunocytochemistry and
subcellular fractionation revealed that eNOS was present in arterioles
and venules and was 67 ± 7% membrane bound. Basal NO release was
60.1 ± 5.1 pM/min ( n = 35), and plasma flow was
2.95 ± 0.27 µl/min ( n = 29). Local NO synthase
inhibition with 30 µM
N -nitro- L -arginine reduced NO
production to 8.6 ± 2.6 pmol/min ( 83 ± 5%,
n = 9) and plasma flow to 1.95 ± 0.15 µl/min
( 28 ± 12%, n = 17) within 30-45 min, in
parallel with constriction of arterioles (9-14%) and venules
(19-25%). The effects of
N -nitro- L -arginine (10-30
µM) were proportional to basal microvascular conductance
( r = 0.7, P |
---|---|
ISSN: | 0363-6135 1522-1539 |
DOI: | 10.1152/ajpheart.2001.280.3.H1222 |